(BHVN) Biohaven Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biohaven Pharmaceutical | (BHVN) share price targets
Complete technical analysis of Biohaven Pharmaceutical (BHVN) by charts plus indicators, forecast predictions and share price targets for Biohaven Pharmaceutical (BHVN)
Biohaven Pharmaceutical trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-12 View latest technical analysis
10 day averaged volume of Biohaven Pharmaceutical is 653570
Date | Daily Closing Price | Open | High | Low | Volume |
12 Tue Nov 2024 | 50.36 | 51.52 | 52.76 | 50.14 | 1.13 times |
11 Mon Nov 2024 | 52.43 | 54.53 | 54.53 | 52.30 | 0.937 times |
08 Fri Nov 2024 | 53.47 | 53.09 | 53.61 | 51.80 | 1.04 times |
07 Thu Nov 2024 | 53.09 | 53.49 | 54.68 | 53.00 | 0.814 times |
06 Wed Nov 2024 | 53.74 | 53.02 | 54.98 | 52.47 | 1.5 times |
05 Tue Nov 2024 | 51.41 | 49.81 | 51.42 | 49.48 | 0.754 times |
04 Mon Nov 2024 | 50.04 | 50.38 | 50.64 | 48.76 | 1.173 times |
01 Fri Nov 2024 | 50.88 | 49.78 | 50.94 | 49.14 | 0.933 times |
31 Thu Oct 2024 | 49.76 | 49.92 | 51.61 | 48.74 | 1.349 times |
30 Wed Oct 2024 | 50.46 | 50.50 | 51.39 | 49.63 | 0.745 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 50.7, but if it comes above 50.7, then a intra day buy could be more profitable.
If you take a sell trade below 50.7, then use 50.7 as stoploss and 49.3 as target. However if you take a buy trade in stock , then use 50.7 as stoploss and 51.82 as target.
Share price targets for Biohaven Pharmaceutical (BHVN)
Target Type | Value |
Downside Target | 32.50 |
Downside Target | 33.17 |
Downside Target | 35.29 |
Downside Target | 41.95 |
Downside Target | 43.19 |
Downside Target | 46.02 |
Downside Target | 48.74 |
Downside Target | 50.14 |
Upside Target | 51.99 |
Upside Target | 53.88 |
Upside Target | 54.63 |
Upside Target | 54.75 |
Upside Target | 54.98 |
Upside Target | 55.70 |
Intraday share price targets for Biohaven Pharmaceutical (BHVN)
Target Type | Value |
Downside Intraday Target | 48.82 |
Downside Intraday Target | 47.29 |
Upside Intraday Target | 53.21 |
Upside Intraday Target | 56.07 |
Upside Intraday Target | 51.68 |
Weekly technical analysis of Biohaven Pharmaceutical (BHVN)
Date | Weekly Closing Price | Open | High | Low | Volume |
12 Tue Nov 2024 | 50.36 | 54.53 | 54.53 | 50.14 | 0.391 times |
08 Fri Nov 2024 | 53.47 | 50.38 | 54.98 | 48.76 | 1.078 times |
01 Fri Nov 2024 | 50.88 | 53.24 | 54.63 | 48.74 | 1.011 times |
25 Fri Oct 2024 | 52.84 | 52.24 | 54.75 | 50.58 | 0.729 times |
18 Fri Oct 2024 | 52.96 | 52.60 | 53.88 | 50.53 | 0.636 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Biohaven Pharmaceutical (BHVN)
Date | Monthly Closing Price | Open | High | Low | Volume |
12 Tue Nov 2024 | 50.36 | 49.78 | 54.98 | 48.76 | 0.243 times |
31 Thu Oct 2024 | 49.76 | 49.38 | 55.70 | 46.02 | 0.87 times |
30 Mon Sep 2024 | 49.97 | 39.07 | 51.99 | 35.29 | 1.586 times |
30 Fri Aug 2024 | 39.40 | 39.00 | 43.19 | 32.50 | 0.828 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biohaven Pharmaceutical (BHVN)
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biohaven Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Biohaven Pharmaceutical in short term but the sell signal is initial and weak.
Biohaven Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Biohaven Pharmaceutical in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Biohaven Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 51.58 and Biohaven Pharmaceutical (BHVN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biohaven Pharmaceutical (BHVN) stock. Volume based technical analysis of Biohaven Pharmaceutical (BHVN) stock is negative.
Biohaven Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biohaven Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Biohaven Pharmaceutical in short term but the sell signal is initial and weak.
Biohaven Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Biohaven Pharmaceutical in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Biohaven Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 51.58 and Biohaven Pharmaceutical (BHVN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biohaven Pharmaceutical (BHVN) stock. Volume based technical analysis of Biohaven Pharmaceutical (BHVN) stock is negative.
Biohaven Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.